Ortiz and colleagues [2] sought to compare the efficacy of amiodarone vs procainamide in patients with hemodynamically stable, regular WCT. The exact diagnosis (eg, VT vs supraventricular tachycardia ...
Can an amiodarone drip be converted to twice-daily IV bolus dosing if the patient is unable to take anything by mouth or nasogastric tube? In conclusion, on the basis of the pharmacokinetic properties ...
Amiodarone HCl 50mg/mL; soln for IV infusion after dilution; contains polysorbate 80. Amiodarone, a class III antiarrhythmic, possesses electrophysiologic characteristics of all four Vaughan Williams ...
Amiodarone is a class III antiarrhythmic drug, with some class IA properties. Amiodarone on rare occasions can induce torsades de pointes within the first 48 hours of intravenous administration, even ...
Inadvertent administration may result in serious adverse events. Mylan announced the voluntary recall to the hospital/clinic level of 4 lots of Amiodarone HCl Injection, USP 450mg/9mL and Tranexamic ...
KING OF PRUSSIA, Pa., Nov. 18, 2010 /PRNewswire/ -- Prism Pharmaceuticals, Inc. announced today that the U.S. Food & Drug Administration (FDA) has approved the supplemental new drug application for ...
Recent-onset atrial fibrillation, defined as an onset within one week, is a major issue in clinical practice, and recent advances have shown that cardioversion to normal sinus rhythm provides better ...
KING OF PRUSSIA, Pa., Jan. 5 /PRNewswire/ -- Prism Pharmaceuticals announced today that the U.S. Food & Drug Administration (FDA) has approved the new drug application (NDA) for NEXTERONE(R) ...
(HealthDay)—In a report published online July 16 in the Journal of Clinical Pharmacy and Therapeutics, a case of survival after acute liver failure secondary to amiodarone administration is described.
What is amiodarone used for? Amiodarone is commonly used to prevent and treat certain types of serious (and sometimes life-threatening) arrhythmias called ventricular fibrillation and ventricular ...
KING OF PRUSSIA, Pa., Jan. 5 Prism Pharmaceuticalsannounced today that the U.S. Food & Drug Administration (FDA) has approvedthe new drug application (NDA) for NEXTERONE(R) (amiodarone HCl) Injection, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results